These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 30237086

  • 1. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
    Daniluk U, Daniluk J, Krasnodebska M, Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM.
    Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
    [Abstract] [Full Text] [Related]

  • 2. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
    Shentova R, Baycheva M, Kofinova D, Hadjiiski P, Yaneva P.
    Folia Med (Plovdiv); 2020 Jun 30; 62(2):271-275. PubMed ID: 32666743
    [Abstract] [Full Text] [Related]

  • 3. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V, Chaparro M, Gisbert JP.
    Dig Liver Dis; 2018 Apr 30; 50(4):353-359. PubMed ID: 29396129
    [Abstract] [Full Text] [Related]

  • 4. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
    Egea Valenzuela J, Pereñíguez López A, Pérez Fernández V, Alberca de Las Parras F, Carballo Álvarez F.
    Rev Esp Enferm Dig; 2016 Jul 30; 108(7):394-400. PubMed ID: 27312194
    [Abstract] [Full Text] [Related]

  • 5. Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.
    Mak LY, Tong TSM, Cheung KS, Chen LJ, Lui KL, Lau KS, Leung WK.
    Clin Transl Gastroenterol; 2020 Mar 30; 11(3):e00138. PubMed ID: 32132451
    [Abstract] [Full Text] [Related]

  • 6. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.
    Fukunaga S, Kuwaki K, Mitsuyama K, Takedatsu H, Yoshioka S, Yamasaki H, Yamauchi R, Mori A, Kakuma T, Tsuruta O, Torimura T.
    Int J Mol Med; 2018 Jan 30; 41(1):107-118. PubMed ID: 29115397
    [Abstract] [Full Text] [Related]

  • 7. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.
    Shaoul R, Sladek M, Turner D, Paeregaard A, Veres G, Wauters GV, Escher J, Dias JA, Lionetti P, Staino A, Kolho KL, de Ridder L, Nuti F, Cucchiara S, Sheva O, Levine A, ESPGHAN Porto IBD Group.
    Inflamm Bowel Dis; 2012 Aug 30; 18(8):1493-7. PubMed ID: 22275268
    [Abstract] [Full Text] [Related]

  • 8. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 30; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 9. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
    van Rheenen PF.
    Inflamm Bowel Dis; 2012 Nov 30; 18(11):2018-25. PubMed ID: 22275341
    [Abstract] [Full Text] [Related]

  • 10. Assessing seasonal variations of biomarkers in inflammatory bowel disease.
    Neamți L, Drugan TC, Drugan C, Silaghi C, Ciobanu L, Ilyés T, Crăciun A.
    Eur J Gastroenterol Hepatol; 2024 Aug 01; 36(8):993-999. PubMed ID: 38973542
    [Abstract] [Full Text] [Related]

  • 11. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H, Desai D, Abraham P, Joshi A, Gupta T, Dherai A, Ashavaid T.
    Indian J Gastroenterol; 2015 Nov 01; 34(6):431-5. PubMed ID: 26589229
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.
    World J Gastroenterol; 2017 Dec 14; 23(46):8235-8247. PubMed ID: 29290660
    [Abstract] [Full Text] [Related]

  • 13. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M, D'Incà R, Basso D, Ruffolo C, Polese L, Bertin E, Luise A, Frego M, Plebani M, Sturniolo GC, D'Amico DF, Angriman I.
    Dis Colon Rectum; 2007 Jun 14; 50(6):861-9. PubMed ID: 17473939
    [Abstract] [Full Text] [Related]

  • 14. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.
    Inflamm Bowel Dis; 2008 Jan 14; 14(1):40-6. PubMed ID: 18022866
    [Abstract] [Full Text] [Related]

  • 15. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E, Seidel L, Colombel JF, Louis E, GETAID (Groupe d'Étude Thérapeutique Des Affections Inflammatoires Digestives).
    J Crohns Colitis; 2013 Dec 14; 7(12):e678-83. PubMed ID: 23845231
    [Abstract] [Full Text] [Related]

  • 16. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.
    Eur J Gastroenterol Hepatol; 2010 Mar 14; 22(3):340-5. PubMed ID: 19581809
    [Abstract] [Full Text] [Related]

  • 17. Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.
    Irwin JR, Ferguson E, Simms LA, Hanigan K, Doecke JD, Langguth D, Arnott A, Radford-Smith G.
    Dig Dis Sci; 2019 Feb 14; 64(2):503-517. PubMed ID: 30478769
    [Abstract] [Full Text] [Related]

  • 18. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan 14; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 19. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 14; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z, Clark N, Park KT.
    Clin Gastroenterol Hepatol; 2014 Feb 14; 12(2):253-62.e2. PubMed ID: 23883663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.